Obesity was initially regarded as a psychosocial disorder, but, after years of study, has
come to be understood as a chronic disease for which there is no cure, like hypertension
and diabetes6
,
7. Surgical intervention is safe and effective in
the long term and aims to control the disease and its comorbidities. Even so, it is hoped
that the proportion of patients who experience long-term recidivism can be reduced1
,
3.In the past 20 years, surgical treatment of obesity has evolved significantly and is
regarded as more than an isolated modification of the digestive tract. This operation, in
combination with changes in lifestyle, is fundamental for controlling the disease in the
long and medium term. These changes can be achieved with appropriate guidance and follow-up
from a multi-professional team5.Comorbidities, such as diabetes, arterial hypertension, sleep apnea and others, reduce
quality of life and increase mortality. Weight loss and control of these disease save lives
and bring down the cost to the healthcare system2,
4
,
8.There is no consensus in the literature as to the definition of successful bariatric and
metabolic surgery. The same outcome can be considered favorable by one author and
unfavorable by another. There is also no unanimity as which treatment option is most
appropriate for turning round a failed bariatric surgery.With a view to drawing up norms as to what constitutes successful bariatric surgery, the
Brazilian Society of Bariatric and Metabolic Surgery-SBCBM-held a discussion forum
involving surgeons, endocrinologists, cardiologists, nutritionists, psychiatrists, and
physical exercise professionals. After critical analysis of the available literature in the
light of the prior experience of participants, objective classification criteria were drawn
up.The following is a list of the final decisions reached by the panel of experts:1. A patient who does not manage adequately to control obesity is different from one who
experiences a relapse after various years of adequate control.2. A small long-term weight gain is normal and to be expected after bariatric and metabolic
surgery.3. The control of metabolic diseases and the consequent improvement in quality of life are
the desired outcomes.4. It is appropriate for the criteria for successful or unsuccessful surgery to employ the
following terms:Controlled obesity: patients who achieve a Total Weight Loss of >
20% in 6 months;Partially controlled obesity: Total Weight Loss of between 10 and 20%
in 6 months;Uncontrolled obesity: Total Weight Loss of < 10% in 6 months.5. Along with the definition of Obesity Control, the following factors should also be taken
into consideration:Patient satisfaction with the outcome;Improvement of associated diseases, irrespective of weight loss;Any weight also occurring prior to surgery.6. For those patients who gain weight after a long period of control or those in whom an
associated disease has reappeared the correct term is obesity recidivism, classified as
follows:Recidivism: 50% of weight lost regained in long term or 20% of weight
regained in association with reappearance of comorbidities.Controlled Recidivism: Between 20 and 50% of weight loss regained in
long term.NB. Expected weight gain: < 20% of weight loss regained in long term.7. The causes of post-operative recidivism are related to factors relating to the patient
(behavioral and biological) and surgical techniques.8. The causes related to recidivism, especially behavioral ones, should first be evaluated
by a multidisciplinary team and then the technical causes should be solved surgically.9. We consider the ideal multidisciplinary team to comprise:an endocrinologista surgeona nutritional doctora psychiatrista nutritionista psychologista physical trainera physiotherapistand other professionals if necessary.Always leading the way, the SBCBM has established guidelines to help orient the outcomes of
bariatric and metabolic surgery. Standardized terms and criteria will lead to standardized
practices and provide better treatment for our patients.It is important to note that this document should not be used for legal purposes, as it
does not deal with legislation on the subject, aiming only to provide instrutions for
members of the society.
Authors: Shahzeer Karmali; Balpreet Brar; Xinzhe Shi; Arya M Sharma; Christopher de Gara; Daniel W Birch Journal: Obes Surg Date: 2013-11 Impact factor: 4.129
Authors: Lars Sjöström; Markku Peltonen; Peter Jacobson; C David Sjöström; Kristjan Karason; Hans Wedel; Sofie Ahlin; Åsa Anveden; Calle Bengtsson; Gerd Bergmark; Claude Bouchard; Björn Carlsson; Sven Dahlgren; Jan Karlsson; Anna-Karin Lindroos; Hans Lönroth; Kristina Narbro; Ingmar Näslund; Torsten Olbers; Per-Arne Svensson; Lena M S Carlsson Journal: JAMA Date: 2012-01-04 Impact factor: 56.272
Authors: Silas M Chikunguwo; Luke G Wolfe; Patricia Dodson; Jill G Meador; Nancy Baugh; John N Clore; John M Kellum; James W Maher Journal: Surg Obes Relat Dis Date: 2009-11-10 Impact factor: 4.734
Authors: David Arterburn; Andy Bogart; Karen J Coleman; Sebastien Haneuse; Joe V Selby; Nancy E Sherwood; Stephen Sidney; Mary Kay Theis; Guilherme M Campos; David McCulloch; Patrick J O' Connor Journal: Obes Res Clin Pract Date: 2013 Jul-Aug Impact factor: 2.288
Authors: Diogo Turiani Hourneaux de Moura; Anna Carolina Batista Dantas; Igor Braga Ribeiro; Thomas R McCarty; Flávio Roberto Takeda; Marco Aurelio Santo; Sergio Carlos Nahas; Eduardo Guimarães Hourneaux de Moura Journal: World J Gastrointest Surg Date: 2022-02-27
Authors: Natália Luiza Kops; Manoela A Vivan; Jaqueline D C Horvath; Mariana L D de Castro; Rogério Friedman Journal: Obes Surg Date: 2018-09 Impact factor: 4.129